Annovis Bio Inc.

ANVS | NYSE

Price Alert Chart Builder DCF Calculator

$1.26

+$0.07 (+5.88%)

At close: Sep 22, 2026, 3:59 PM ET

$1.21

-$0.05 (-3.96%)

After-hours: Sep 22, 2026, 5:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $50.62M

Enterprise Value $-18.68B

Beta 1.24

Average Volume 978.69K

Shares Outstanding (Diluted) 37.52M

Shares Change YoY 92.54%

Institutional Ownership 16.96%

Exchange NYSE

ISIN US03615A1088

Price Performance

Price Change 1M -35.0%

Price Change 3M -31.6%

Price Change 6M -46.4%

Price Change YTD -67.4%

Price Change 1Y -48.7%

Price Change 3Y -88.0%

Price Change 5Y -96.5%

1M CAGR (ann.) -36.7%

1Y CAGR (ann.) -49.4%

5Y CAGR (ann.) -48.9%

All-Time CAGR -26.9%

Valuation

PE Ratio -0.66

Forward PE N/A

PEG Ratio 0.59

Forward PEG 0.02

PS Ratio N/A

Forward PS 3.00

PB Ratio -0.01

P/FCF Ratio -0.00

P/Adj. FCF Ratio -0.00

P/OCF Ratio -1.03

EV/Sales N/A

EV/EBIT 380.56

EV/EBITDA 380.56

EV/FCF 0.60

Earnings Yield -151.3%

FCF Yield -61111.6%

Adj. FCF Yield -64652.0%

Financial Health

Net Cash $18.73B

Total Debt $0

Cash & Short-Term Investments $18.73B

Total Assets $22.04B

Current Ratio 2.95

Quick Ratio 2.95

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -31.16

Altman Z-Score -12.47

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -5.8%

Returns

Return on Assets -224.7%

Return on Equity -686.0%

Return on Invested Capital -400.4%

Return on Capital Employed -315.9%

Return on Tangible Assets -224.7%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 47.5%

EPS CAGR 5Y 16.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y -149.6%

FCF CAGR 5Y -99.6%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 9

EPS Growth Next 3Y 45.2%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.30

EPS Growth Est (next Q) -18.9%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $25.67

Price Target Upside 2057.1%

Cash Flow

Operating Cash Flow $-30.94B

Free Cash Flow $-30.94B

Adj. Free Cash Flow $-32.73B

FCF Per Share -$1.16

OCF Per Share -$1.16

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-49.53M

EBITDA $-49.08M

Net Income $-14.86B

EPS (Diluted) -$1.80

Revenue / Employee N/A

Profit / Employee $-2.12B

Employees 7